abs198.txt	therapeutic	agents	used	in	the	treatment	of	cancer	are	known	to	developresistance	against	cancer	cells		hence		there	is	a	continuing	need	to	investigatenovel	agents	for	the	treatment	and	management	of	cancer		antitumor	activity	ofgreensporone	c	(gc)		a	new	resorcylic	acid	lactone	isolated	from	an	organicextract	of	a	culture	of	a	halenospora	sp		freshwater	fungus		was	subjected	forscreening	against	a	panel	of	leukemic	cell	lines	(k562		u937		and	ar320)		in	allthe	three	cell	lines		cell	proliferation	was	inhibited	in	dose-dependent	fashion	gc	further	arrested	the	cells	in	subg0	phase	in	dose-dependent	manner		annexinv/pi	dual	staining	data	confirmed	apoptotic	death	of	treated	k562	and	u937leukemic	cells		treatment	with	gc	suppressed	constitutively	phosphorylated	aktand	downregulated	expression	of	inhibitor	of	apoptotic	proteins	xiap		ciap-1		andciap-2		in	summation	to	this		gc-treated	leukemic	cells	upregulated	proteinexpression	of	pro-apoptotic	proteins		bax	with	concomitant	decrease	in	expressionof	anti-apoptotic	proteins	including	bcl-2	and	bcl-xl		upregulation	of	bax	wasassociated	with	cytochrome	c	release	which	was	confirmed	from	the	collapse	ofmitochondrial	membrane		released	cytochrome	c	further	activated	caspase	cascadewhich	in	turn	initiated	apoptosis	process		anticancer	activity	of	this	isolatedfungal	compound	gc	was	potentiated	via	stimulating	production	of	reactive	oxygenspecies	(ros)	along	with	depletion	of	reduced	glutathione	(gsh)	levels	in	k562and	u937	leukemic	cells		pretreatment	of	these	cells	with	n-acetyl	cysteineprevented	gc-induced	depletion	of	reduced	gsh	level	andmitochondrial-caspase-induced	apoptosis		altogether		our	data	show	that	gcmodulates	the	apoptotic	response	of	human	leukemic	cells	and	raises	thepossibility	of	its	use	as	a	novel	therapeutic	strategy	for	hematologicalmalignancies	
